Today: 26 June 2026
Browse Category

NASDAQ:IBIO 21 October 2025 - 13 March 2026

ImmunityBio Stock Jumps After NK-Cell Manufacturing Update Puts Anktiva Expansion Back in Focus

ImmunityBio Stock Jumps After NK-Cell Manufacturing Update Puts Anktiva Expansion Back in Focus

ImmunityBio shares jumped 10.5% to $8.64 by early afternoon Friday after the company announced completion of a scalable manufacturing process for its NK-cell therapy platform. The update follows FDA acknowledgment of a resubmitted application for expanded use of Anktiva in papillary bladder cancer and recent approval of the drug in 33 countries. Investors remain cautious due to ongoing regulatory and financial risks.
13 March 2026
·
iBio (IBIO) Stock Jumps on Obesity Drug Momentum: All the Latest News, Analyst Targets and 2026–2027 Outlook (December 9, 2025)

iBio (IBIO) Stock Jumps on Obesity Drug Momentum: All the Latest News, Analyst Targets and 2026–2027 Outlook (December 9, 2025)

iBio, Inc. shares surged 39% Monday to close at $1.67 on heavy volume, lifting its market value to about $37.5 million. The stock traded higher pre-market Tuesday, with quotes between $1.76 and $1.81. The company reported $49.6 million in cash after a recent offering and says this will fund operations into late 2027. Lead obesity drug candidate IBIO-610 has shown fat-selective weight loss in animal studies.
9 December 2025
·
iBio Stock Surges on Bullish Analyst Calls and Obesity Drug Breakthroughs

iBio Stock Surges on Bullish Analyst Calls and Obesity Drug Breakthroughs

iBio (NASDAQ: IBIO) traded at $0.89 midday October 21, down 63% year-to-date from $2.45 in January. Shares jumped over 20% last week after bullish “Outperform” ratings from Oppenheimer and Leerink Partners, with price targets of $5.00 and $2.00. The company reported positive preclinical results for its obesity drug IBIO-610 and raised $50 million in a recent offering. Market cap stands near $18 million.
21 October 2025
·

Stock Market Today

  • Hon Hai Precision Industry Subsidiaries Declare Over $4.3 Billion in Dividends
    June 26, 2026, 8:24 AM EDT. Hon Hai Precision Industry's subsidiaries announced substantial cash dividends totaling over USD 4.3 billion on June 26, 2026. China Galaxy Enterprises Limited-HK declared USD 1.12 billion, Best Behaviour Holdings Limited-BVI USD 1.57 billion, Foxteq Holdings Inc. USD 26.8 million, and Foxconn (Far East) Limited-Cayman USD 1.68 billion. Additionally, HONGFUJIN Precision Electronics (Zhengzhou) Co., Ltd. announced RMB 2.23 billion. These dividends reflect strong financial returns to shareholders following board resolutions on the same date. The announcements were made via the London Stock Exchange's RNS platform, underlining transparent market communication.

Latest News

Go toTop